Pilot study for compact microbeam radiation therapy using a carbon nanotube field emission micro-CT scanner by Hadsell, Mike et al.
Pilot study for compact microbeam radiation therapy using a carbon
nanotube field emission micro-CT scanner
Mike Hadsell,a) Guohua Cao, Jian Zhang, Laurel Burk, and Torsten Schreiber
Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27599
Eric Schreiber and Sha Chang
Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina 27599
Jianping Lu and Otto Zhou
Department of Physics and Astronomy, University of North Carolina, Chapel Hill, North Carolina 27599
(Received 4 September 2013; revised 2 April 2014; accepted for publication 14 April 2014;
published 15 May 2014)
Purpose: Microbeam radiation therapy (MRT) is defined as the use of parallel, microplanar x-ray
beams with an energy spectrum between 50 and 300 keV for cancer treatment and brain radio-
surgery. Up until now, the possibilities of MRT have mainly been studied using synchrotron sources
due to their high flux (100s Gy/s) and approximately parallel x-ray paths. The authors have pro-
posed a compact x-ray based MRT system capable of delivering MRT dose distributions at a high
dose rate. This system would employ carbon nanotube (CNT) field emission technology to create an
x-ray source array that surrounds the target of irradiation. Using such a geometry, multiple collima-
tors would shape the irradiation from this array into multiple microbeams that would then overlap or
interlace in the target region. This pilot study demonstrates the feasibility of attaining a high dose rate
and parallel microbeam beams using such a system.
Methods: The microbeam dose distribution was generated by our CNT micro-CT scanner (100 μm
focal spot) and a custom-made microbeam collimator. An alignment assembly was fabricated and
attached to the scanner in order to collimate and superimpose beams coming from different gantry
positions. The MRT dose distribution was measured using two orthogonal radiochromic films em-
bedded inside a cylindrical phantom. This target was irradiated with microbeams incident from 44
different gantry angles to simulate an array of x-ray sources as in the proposed compact CNT-based
MRT system. Finally, phantom translation in a direction perpendicular to the microplanar beams was
used to simulate the use of multiple parallel microbeams.
Results: Microbeams delivered from 44 gantry angles were superimposed to form a single microbeam
dose distribution in the phantom with a FWHM of 300 μm (calculated value was 290 μm). Also, dur-
ing the multiple beam simulation, a peak to valley dose ratio of ∼10 was found when the phantom
translation distance was roughly 4x the beam width. The first prototype CNT-based x-ray tube dedi-
cated to the development of compact MRT technology development was proposed and planned based
on the preliminary experimental results presented here and the previous corresponding Monte Carlo
simulations.
Conclusions: The authors have demonstrated the feasibility of creating microbeam dose distributions
at a high dose rate using a proposed compact MRT system. The flexibility of CNT field emission x-ray
sources could possibly bring compact and low cost MRT devices to the larger research community
and assist in the translational research of this promising new approach to radiation therapy. © 2014
American Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4873683]
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small fields
1. INTRODUCTION
Increasing the therapeutic ratio between tumors vs normal
tissue of radiation therapy has long been the goal of radia-
tion oncologists and physicists. Although many strides have
been made, no technique or specialized type of particle has
succeeded in completely sparing the normal tissues.1, 2 A
completely new technique, called microbeam radiation ther-
apy (MRT), initially heralded by research started over half a
century ago,3 has recently sparked renewed interest and has
shown promise in achieving complete normal tissue sparing
during radiation therapy.4, 5 MRT uses multiple planes of ra-
diation that are on the order of tens of micrometers wide and
separated by only hundreds of micrometers. Research con-
ducted at several synchrotron facilities has shown that nor-
mal tissue in rats, suckling piglets, and duck embryos can
withstand MRT with entrance doses of over 1000 Gy with-
out evidence of injury or loss of function.6–8 In vivo ab-
lation of highly aggressive, radioresistant gliosarcomas in
the rat brain and an increase in the rats’ average lifespan
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sometimes by more than a factor of ten have also been
reported.9, 10
MRT is attractive for human application because of its ex-
ceptional ability to selectively eradicate tumors with minimal
damage to the normal tissue structure with virtually no loss of
function.11 However, this technique has neither made its way
to the clinic nor have researchers developed a complete the-
ory as to how it results in tumor ablation.12–14 This is partly
because, currently, high resolution spatially fractionated mi-
crobeam radiation is only generated using the ultra-high dose
rate and nearly parallel synchrotron radiation available at a
few remote locations. Moreover, the dose fall-off with in-
creasing tissue depth of these lower energy sources would be
quite prohibitive in human patients. Conventional megavolt-
age sources used in clinical radiation therapy machines can-
not, however, create the low valley doses needed for the MRT
therapeutic effect because of the secondary electrons scattered
into the valleys between the microbeam peaks, and thus can-
not possibly be used to bring MRT to the clinic.4, 15–18
In addition, the ultra-high treatment dose of 102–103 Gy
delivered in less than a second and in a single treatment frac-
tion at synchrotron facilities has traditionally been thought to
be essential to minimize motion induced broadening of the
radiation track.4 This high dose rate, however, is several or-
ders of magnitude higher than what is afforded by current
orthovoltage x-ray tube technology in which the photon flux
is limited by the anode heat load. In addition, collimating
the intrinsically divergent radiation from the x-ray tube to
the desired microbeam pattern would even further reduce the
dose rate.19–22 Therefore, to the best of our knowledge, MRT
has not been generated by nonsynchrotron sources up to this
point.
Based on the novel carbon nanotube (CNT) field emission
x-ray source array technology we recently proposed a com-
pact microbeam irradiator for small animal studies.23 This
device will take advantage of two key attributes of CNT x-
ray technology: (1) a spatially distributed source array with
flexible source configuration24–27 and (2) the capability for
electronic gating.28–30 Using the first attribute, a higher mi-
crobeam dose rate compared to point focus x-ray tubes will
be achieved by distributing the electron beam energy along
a long and narrow focusing track. And by using the second
advantage, synchronizing irradiation with respiratory and car-
diac cycles will minimize microbeam broadening from physi-
ological motion. This could potentially eliminate the reliance
on synchrotron-level high dose rate.
Finally, we have previously shown using Monte-Carlo sim-
ulation that it should be possible to overlap many of these mi-
crobeam arrays coming from various entrance angles in order
to mitigate the steep dose fall off with distance and penetra-
tion depth that is typically encountered when using divergent,
low-energy sources.31 Providing that all the beams overlap in
exactly the same plane, the microbeam dose distribution both
inside and outside the target region should be retained, thus
retaining the tumor-specific killing power of MRT as demon-
strated at synchrotron sites. Finally, if a sufficient number of
beams are used, the peak dose in such a configuration should
actually be higher within the target than at the surface, as il-
lustrated in Fig. 1.
Based on these considerations, the goals of this pilot study
were to (1) demonstrate microbeam radiation using a sealed
CNT x-ray tube that generates a diverging cone-beam instead
of the nearly parallel beam from the synchrotron source; (2)
evaluate the dose rate and dose distribution that can be ob-
tained with a distributed source array; and (3) estimate the
x-ray power needed to generate microbeam radiation with a
workable dose rate for small animal radiation. The results pro-
vide a guideline for the design of a higher dose rate system
using the distributed x-ray source array technology.
For this feasibility study, a low-power and low-energy mi-
crofocus x-ray tube mounted on a micro-CT scanner with a
rotating gantry was used and a custom motorized microbeam
collimator was designed. A distributed, circular source array
configuration was simulated by rotating the x-ray tube around
the gantry, and microbeams with widths of 300 μm and
∼10 peak-to-valley dose ratios at the center of the phantom
FIG. 1. Illustration of overlapping concept. (a) Multiple MRT microbeam arrays from separate orthovoltage x-ray tubes overlapping in the center of a cylindrical
phantom. (b) Simulated dose distribution showing how the weak penetration of orthovoltage x-rays may be mitigated by overlapping several microbeams.
Diagrams shown here are for illustrative effect only and do not directly correspond to each other or to studies presented in this work.
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were obtained. Finally, a total dose of 34 cGy was achieved
with the x-ray tube operating at 50 kVp and 110 mAs of
on-time.
2. MATERIALS AND METHODS
2.A. Micro-CT scanner
A pre-existing cone-beam micro-CT scanner is used as a
low-power model of a rotating therapeutic x-ray source. It
consists of a microfocus CNT field emission x-ray tube and
a commercial flat panel x-ray detector (C7940DK-02, Hama-
matsu) mounted on a rotating gantry as described in previous
works.29, 32, 33 The x-ray tube produces an effective 100 μm
isotropic focal spot as viewed through a 0.2 mm thick beryl-
lium x-ray window. The anode was given a voltage of 50 kV,
while the cathode was set at a duty cycle of 10% and cur-
rent of 1 mA. Based on a previously measured cathode-gate
transmission rate of 50% for this scanner,34 this translates to
0.05 mAs of tube current per cathode pulse.
For this set of experiments, the source to axis distance was
increased to 16 cm from 12 cm to allow for the placement
of a custom-made microbeam collimator alignment assembly
described below. The noncollimated entrance dose rate was
calculated to be 0.47 cGy/mAs at the increased source to axis
distance, based upon a simple inverse-square correction and
the previously measured dose rate of the scanner.32
2.B. Phantom construction and film measurement
A specialized phantom and holder were designed that at-
tached to the preexisting mouse stage (Velmex, Bloomfield,
NY) of our micro-CT scanner, which is capable of micrometer
precision in positioning. The phantom itself was constructed
out of a 25 mm diameter, 127 mm long acrylic cylinder cut
into four quadrants as shown in Fig. 2. Crossing Gafchromic
XR-QA films (Ashland Advanced Materials, Covington, KY)
were placed in the phantom for all qualitative experimentation
listed below.
FIG. 2. Labeled photograph of phantom with crossed Gafchromic R© EBT2
film sandwiched inside.
Films were scanned in a flatbed scanner (Epson V700)
with an interpolated 2 μm resolution and dose profiles were
attained by analyzing the data in ImageJ (National Institutes
of Health). To attain dose profiles across the line patterns pro-
duced, microbeam lines were aligned orthogonally by image
rotation and pixel values were averaged along a thick rectan-
gle crossing and covering the beam pattern in question. These
values were converted to net optical density (netOD) using the
standard method,35 and then the netOD was plotted with po-
sition and labeled as relative dose using Microsoft Excel. No
calibration curve for fitting optical density to dose was created
because only relative dose profiles were needed for qualitative
study.
For quantitative study, crossing Gafchromic EBT2 films
(Ashland) were used instead of XR-QA due to the need to
measure an absorbed dose outside the range of XR-QA. For
dose readout of the EBT2 film, a dose calibration curve cre-
ated for use in the CyberKnife R© suite of the North Carolina
Cancer Hospital was employed. After irradiation, the crossed
films were removed from the phantom and sent to the hospital
to be analyzed.
2.C. Collimator assembly
The cone beam radiation from the microfocus tube was
collimated into a submillimeter fan beam, as illustrated in
Fig. 3(a), using a custom-made microbeam collimator affixed
to the x-ray window of the micro-CT scanner as shown in
Fig. 3(b). This collimator was fashioned from two stain-
less steel gauge blocks (Mitutoyo, Japan) clamped together
against two 220 μm glass spacers. The resulting collimator
was 25 mm thick with a 25 mm long and 220 μm thick slit.
The alignment system was designed with the ability to trans-
late in a direction perpendicular to the plane of gantry rota-
tion, pitch in a direction above and below the gantry plane,
and roll around the axis of the cone beam, also as shown in
Fig. 3(b). Using these three degrees of freedom, the collimator
was aligned in such a way to create a fan beam that would be
precisely in the plane of gantry rotation regardless of gantry
angle.
2.D. Microbeam creation
The translation stage (Model 426A with TRA25PPM actu-
ator, Newport Corporation, Irvine, CA) was scanned through
its range of motion to find the setting at which the focal spot
was brightest as seen through the collimator by looking at its
live image on the x-ray detector. After finding this initial po-
sition, a single strip of XR-QA film was irradiated from two
opposing horizontal positions (which will be designated as 0◦
and 180◦ from here on) of the x-ray tube on the gantry, creat-
ing a crossed line pattern on the film. The angle between the
crossed lines was noted and the roll angle was adjusted with
the first rotation stage (Newport model RS-65 with SM-13
actuator). This process was repeated until there was no dis-
cernible angle between the lines created on the film, indicat-
ing proper alignment and beam overlap. A similar procedure
employing an edge-on irradiation of film and an adjustment of
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FIG. 3. (a) Diagram illustrating the process of microbeam irradiation using our microfocus x-ray tube. (b) SolidworksTM representation of the x-ray tube and
collimator alignment assembly showing degrees of freedom necessary to select the appropriate collimation microplane that will coincide with the gantry’s plane
of rotation. (X-ray window not shown because it is covered by the alignment assembly.)
the other rotation stage (Newport model RS-65 with NSA12
actuator) was used to align the pitch angle. During these
initial alignment procedures, it was assumed and seen that the
pitch and roll angular adjustments followed the small-angle
approximation and thus were linearly independent.
After alignment, a 1.5 mm thick piece of lead with a 5
mm aperture was affixed to the exit side of the collimator
to give the resultant microbeam a smaller length, creating a
microbeam that diverged to become 6.5 mm × 300 μm at
isocenter. As a final step, a 0.5 mm thick aluminum sheet was
placed behind the collimator for beam filtration, giving the
final emerging x-ray spectrum a median energy of 30 keV.36
3. EXPERIMENTAL PROCEDURES
3.A. Beam width measurement and overlap
verification
In order to verify microbeam overlap from multiple gantry
positions, we elected to use entrance angles in four sections of
60◦, each centered on one of the four main axes as shown in
Fig. 4. Each of the four sections is separated into 11 different
entry ports spaced evenly at 6◦ apart. Collimator adjustments
were needed to account for initial misalignment of the verti-
cal beams due to a small angular deflection in the gantry arm
under the weight of the x-ray tube for the top and bottom sec-
tions. No such corrections were necessary for the right and
left segments.
Ten 0.05 mAs pulses were delivered from each entry port
to accumulate enough dose on the film for suitable readout.
After irradiation, the crossed films were removed from the
phantom and scanned according to the procedures previously
detailed. The scans were then analyzed for beam overlap and
alignment by comparing the beam width with that of a beam
incident from only one direction. Also, films were qualita-
tively examined for dose accumulation in the center of the
phantom to show the feasibility of experimentally recreating
results similar to those demonstrated in our previous simula-
tion study.31
3.B. Peak to valley dose ratio
The peak to valley dose ratio (PVDR), as illustrated in
Fig. 5(b), has been shown to greatly affect the therapeutic
ratio of MRT treatment.10, 37, 38 Therefore, we measured the
PVDR at center-to-center beam spacings of 600, 900, and
1200 μm in order to determine which beam spacing would
produce values of ∼10 for this parameter given our divergent
source. For this experiment, only the 0◦ and 180◦ entrance an-
gles were used. A pattern of five microbeams was delivered to
the phantom and film as shown in Fig. 5(a), each consisting
of 120 pulses from each of the two opposing directions. The
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FIG. 4. Scale drawing of radiation pattern for overlap experiment. Incoming
irradiation was evenly distributed within the four 60◦ sections shown using
11 separate entrance angles from each section. Four quadrant circle in the
center represents the phantom and the outer arcs represent the path of the
focal spot around the gantry isocenter.
pattern was delivered by setting the gantry to the 0◦ angle,
delivering the 120 pulses to the phantom, and then translating
the phantom along its axis by the designated beam spacing af-
ter each set of pulses. The gantry was then rotated to the 180◦
angle and the steps of the first pattern were retraced, creat-
ing microbeams that would overlap with the first set of five
beams. After irradiation, the film was scanned and the ratio
between the average peak and valley doses was calculated for
each of the three beam spacings.
3.C. Interlacing beams demonstration
Due to the fact that synchrotron MRT research groups have
begun to explore the efficacy of interlaced microbeams in the
treatment of neurological disorders and brain tumors,12, 39–42
the capability to interlace microbeams incident from different
entrance angles was also demonstrated. This experiment used
only the four main axes for entrance angles, giving 132 pulses
of 0.05 mAs from each direction. The beams from the 0◦
and 180◦ directions were spaced by 900 μm center-to-center
along the axis of the phantom and offset from the beams inci-
dent from the 90◦ and 270◦ angles by half this spacing. Five
beams were incident from the 0◦ and 180◦ directions and in-
terlaced with four beams incident from the 90◦ and 270◦ di-
rections. The method of creating this spacing was similar to
that described for the PVDR study above. Finally, the film
was removed from the phantom, scanned, and qualitatively
examined for interlacing capabilities.
3.D. Preliminary dose rate measurement
A quantitative dose experiment was performed to provide
an extrapolated estimate for the capabilities of a full-scale de-
vice. This experiment was set up in the same manner as the
FIG. 5. (a) In our setup, five x-ray microbeams are incident on a cylindrical
plastic phantom from both sides. (b) Idealized dose distribution illustrating
the characteristic high peaks and low valleys inherent to MRT dose distribu-
tions. As noted in the text, control of the PVDR is essential to retaining a high
therapeutic ratio.
qualitative overlap study above with the additional caveat that
fifty 0.05 mAs pulses were given from each of the 44 entry
angles instead of ten. After films were analyzed as described
previously, the maximum dose measured at the center of the
phantom was combined with proposed device specifications
for our full-scale device to extrapolate an estimate of its pro-
jected dose rate. For this projection, the following relationship
between the output power (P) of an x-ray tube and its opera-
tional parameters was used.
P ∝ IZV 2. (1)
This proportionality was derived from the standard
equation for the total unfiltered radiant energy from the
bremsstrahlung spectrum of a reflective anode type x-ray
tube.43 In this equation, V refers to the anode voltage which
accelerates the electrons toward the reflective target, I repre-
sents the amount of electron current from the cathode that im-
pinges on the anode target to create x-rays, and Z is the atomic
number of this anode target material.
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FIG. 6. Results of the overlap experiment showing (a) the inverted grayscale image of the vertical irradiated film, (b) a graph of relative dose displaying the
dose profile along the width of the overlapped microbeams, and (c) a graph of the dose along the length of the irradiated line displaying roughly double the dose
in the center of the phantom than in the peripheral areas.
4. RESULTS
4.A. Beam width measurement and overlap
verification
After initial collimator alignment, it was observed that the
combined beam width of two opposing overlapped beams as
marked on film was 290 ± 30 μm. The width of a single
nonoverlapped beam at the isocenter of the micro-CT scan-
ner was calculated to be around 300 ± 20 μm using geo-
metric considerations. From these measurements, it can be
concluded that the overlap of the two beams is coincidental
to within the intrinsic error of our measurement technique.
It was also observed that the width of the overlapped beams
as marked on film does not display additional widening at the
edges of the phantom, indicating that the beams do not merely
cross at the isocenter, but rather overlap through the entirety
of their transmission through the phantom.
During the experiment in which microbeams were over-
lapped from 44 different entrance angles, the FWHM of the
resulting beam was 300 μm, as shown in Fig. 6(b). This was
only 3.4% wider than the measurement only involving two
opposing beams described above. In addition, the beam width
near the edges of the phantom still displayed the same width
as a single beam. As shown in Fig. 6(c), which represents a
measurement of dose along the beam path in the vertical di-
rection, relative dose in the center of the phantom was mea-
sured to be roughly two times higher than dose in the sur-
rounding material.
4.B. Peak to valley dose ratio
During the PVDR study, center-to-center beam separations
of 600, 900, and 1200 μm respectively produced PVDRs of
5.1, 8.6, and 9.6 at the center of the phantom as shown in the
film scans from the PVDR study displayed in Fig. 7, with re-
sults listed in Table I. Due to a considerable amount of signal
noise in the valley for the 1200 μm case, it was necessary
to average the dose within this region rather than simply use
the minimum to calculate PVDR. To do this, the valley re-
gion was defined to be anywhere between two peaks where
the dose was less than D10 as defined below.
D10 = 0.1 × (D̄max − D̄min) + D̄min. (2)
In this formula, D̄min represents the average minimum
dose in the valleys and D̄max represents the average peak dose.
Also using this formulation, a valley width for each of the
three spacings was calculated using the D10 positions within
the distributions. These were calculated to be 190, 450, and
620 μm and are also displayed in Table I.
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FIG. 7. Films and dose profiles of microbeams delivered with different center to center (c-t-c) spacings. Vertical axes in graphs (d)–(f) represent relative dose
(normalized to the maximum dose). Film (a) and profile (d) of 290 μm microbeams delivered at 600 μm c-t-c spacing. Film (b) and profile (e) of similar beams
delivered at 900 μm spacing. Note that there was an error in delivery in the fifth beam so only the previous four were used in the PVDR and valley width
calculations. Film (c) and profile (f) of beams delivered at 1200 μm spacing. Also note the higher noise level in the valley at the largest c-t-c spacing, indicating
the possibility of a lack of measurable dose in this region.
4.C. Interlacing beams demonstration
In this study, we were successful in placing one pattern
inside the other (as shown in Fig. 8), thus creating a dose
pattern that was a well-defined microbeam distribution out-
side the target area, but that delivered twice the density of
dose inside the target area, effectively doubling the dose vol-
ume. As a side note, it can be seen from the film that beams
incident from the direction parallel to the film produce less
signal than perpendicularly incident beams even though the
same amount of beam on time was used. This inconsistency
was to be expected, though, since numerous studies have re-
ported conflicting results on film behavior when it is irradiated
parallel to the film plane as opposed to perpendicularly.44–46
Therefore, a relative dose profile for this film is excluded from
this work.
4.D. Preliminary dose rate measurement
The peak dose measured by the EBT2 film in our quanti-
tative measurement was 34 cGy and the FWHM was found to
TABLE I. PVDR and valley width for various center-to-center beam sepa-
rations of our microbeams. Microbeams had FWHM values of 300 μm. All
results here are averaged over all peaks (or valleys) in the array.
Beam pitch Beam ctca spacing PVDR Valley width
1:2 600 5.1 190
1:3 900 8.6 450
1:4 1200 9.6b 620
aCenter to center.
bModified PVDR value that uses average relative dose across the valley regions to
mitigate noise in the signal.
be identical to that shown above. Using the previously mea-
sured dose rate of the micro-CT tube and assuming nearly
ideal dose accumulation from the overlapping microbeams,
the 2200 pulses of 0.05 mAs each should have resulted in a
dose of 52 cGy with no attenuation. When accounting for the
attenuation of the 1.25 cm of acrylic with tabulated mass at-
tenuation coefficients47 at our median x-ray energy of 30 keV,
however, the expected dose value for this experiment is found
to be 33 cGy, which compares well with the measured value
and again indicates good overlap and collimator transmission.
Finally as can be seen in Table II, this measurement for
the micro-CT setup corresponds to an instantaneous dose rate
of 0.00154 Gy/s or 3.1 Gy/As. Therefore, based on the pre-
liminary specifications of the proposed compact CNT MRT
device (also as seen in Table II) and an extrapolation based on
the use of Eq. (1) as described above, an instantaneous dose
rate of 100 Gy/s should be achievable given an anode current
FIG. 8. Scanned image of film in which beams were overlapped from op-
posing directions and interlaced in perpendicular directions. Dose volume
was doubled in the target region while surrounding regions only see a typical
microbeam pattern. The relative dose profile for this film has been omitted
because of inconsistencies in film response when beams are incident edge-on
to the film.
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TABLE II. Calculation of the necessary tube current (A) to achieve 100Gy/s (dose rate) in the prototype device based upon the measured MRT dose rate using
the micro-CT scanner. Note that the different configuration source distances necessitate an inverse-square correction in addition to those indicated in the text.
Device configuration Tube current Anode voltage (kV) Anode material (Z) Source distance (cm) Dose rate (Gy/s)
Micro-CT 0.5 mA 50 Mo (42) 16 0.00154
Prototype 1.0 A 160 W (74) 12 100
of around 1 A, an anode voltage of 160 kV, an anode target
material made from tungsten, and a source to target distance
of 12 cm.
5. DISCUSSION
As was seen from the results of initial alignment and the
overlap of collimated microbeams from opposing angles, the
machinery designed for this work proved quite capable of cre-
ating microbeams from our CNT x-ray source and superim-
posing them within the target. In regards to the experiment in
which multiple entrance angles were used, the achieved align-
ment was better than expected based upon on the previously
imperceptible deformation of the plane of rotation under the
weight of the x-ray source. It was also noted that the beam
width remained fairly constant even outside the target region,
indicating that beam alignment was not only sufficient to pro-
vide overlap within the target region, but also to maintain the
integrity of a delivered microbeam array outside the target re-
gion. This is an ability that will be essential to sparing normal
tissue surrounding targeted tumors in MRT treatments.
Although the data on beam width and alignment is quite
conclusive, results involving the dose addition in the target
region where beams were overlapped must only be consid-
ered qualitatively due to the nature of our setup. Various stud-
ies have shown that discrepancies in quantitative analysis can
arise when irradiating film in an orientation parallel to the
beam path and sandwiching film in plastic phantoms with pos-
sible air gaps.44–46 Therefore, even though the film showed
an increase in measurable signal within the targeted region
when compared to the signal in the periphery of the phantom,
how much of a corresponding increase in dose is unknown
because half of the irradiation was delivered perpendicular to
the film while the other half was incident edge-on. Therefore,
this study cannot be used as a quantitative result to compare
with simulations done in earlier work, both because of this
lack of reliable quantitative data and large differences in ex-
perimental setup.31 Regardless, it does show that achieving a
microbeam dose within the target region of a small irradiated
subject that is higher than the dose at its periphery is possible
with methods of alignment such as those shown here.
After an analysis of the results from the PVDR study, a
beam width to separation distance ratio of approximately 1:4
for future designs was decided upon due to this configura-
tion’s average valley width of 620 μm and PVDR of 9.6. We
considered this to be the minimum value for PVDR, with the
valley widths and PVDR values of the other configurations
deemed to be too small to allow for normal tissue repair when
giving peak doses on the order of 100s of Gy based upon stud-
ies done at synchrotron facilities.7, 10, 48 The reason our PVDR
is lower than those measured in synchrotron studies that em-
ploy similar beam widths but smaller beam separations12, 39, 40
is clearly due to the divergent nature of our beam. In addi-
tion to the fact that this divergence causes a non-negligible in-
crease of beam size in both the length and width as the beam
penetrates the target region, it will also produce much more
collimator scatter before the target region is even reached.
This will in turn increase valley dose beyond what is seen
from the quasi-parallel beams produced at synchrotron sites49
and subtract from peak dose. Therefore, a larger beam sep-
aration is warranted and necessary when using a divergent
source.
The qualitative study on interlacing capabilities further
highlighted the utility of our collimation system and micro-
focus x-ray tube by demonstrating its ability to construct mi-
crometrically accurate dose distributions within the target re-
gion of the phantom. In this way, a table-top system of this
type could create microbeam distributions such as those seen
in various synchrotron studies that overlap, interlace, or cross
in the target region to increase the peak dose and/or the val-
ley dose given to the target.9, 40–42 Moreover, this experiment
displayed the conjunction of microbeam overlap with inter-
lacing. Expanding this concept to multiple gantry angles on a
larger phantom would allow for the possibility of simultane-
ously producing a maximum continuous dose distribution at
the target while leaving a lower-dose, microbeam dose distri-
bution in the surrounding regions by using a fraction of the
angles for overlap and the remaining fraction for interlacing.
In this way, both dose magnitude and volume can be increased
at the target.
Finally, we have demonstrated that we should be able to
scale-up to a device with a power high enough to deliver ef-
fective MRT doses (100s of Gy) in a reasonable time scale,
given the 160 kV anode voltage and compact sizes achievable
using our CNT cathode devices.50 It should be noted that even
at the projected dose rate of 100 Gy/s, physiological gating as
shown by Cao et al.32 may still be necessary if cardiosyn-
chronous motion of the cerebral microvasculature is strong
enough to blur the microbeam pattern. Even if such gating re-
duces the effective dose rate by 20x, though, a microbeam pat-
tern with five beams, each with a depth dose of 600 Gy would
still be possible within 10 min given a single distributed line
source with a 100 Gy/s instantaneous dose rate. Moreover,
given the preliminary device specifications above, the dose
rate will likely be even higher, seeing as how our rudimen-
tary extrapolation was based upon depth dose, which would
increase appreciably at 160 kVp.
Such a device will be tenable through the use of our CNT
source arrays to spread the anode heat load necessary for such
a high dose rate into a large enough focal area. Based on the
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results of this study, it is feasible to align microbeams cre-
ated from a single divergent source and collimator into a sin-
gle microplane in the target region. Therefore, the concept of
surrounding a target with multiple small line sources and col-
limating the set of axially symmetric microbeams all into a
single plane, also as described by Schreiber et al.,31 will also
be possible. This will allow for the large anode area needed
to dissipate the amount of heat that will be created from over
an amp of anode current. Similar to the typical x-ray tube de-
sign in which a rotating anode spreads the heat from one focal
spot around a full circle of the anode to create a highly lu-
minous single source, this design would also spread the heat
across a large circular path. But in this case, the path would
be much larger because it would encompass the irradiation
target, not require rotation, and make use of a large number of
much weaker sources to create a much more favorable dose
distribution in the subject.
6. CONCLUSIONS
It has been shown here that microbeam dose profiles can
be created from a microfocus x-ray tube with the addition
of a precise collimator alignment system. In addition, the
possibility of microbeam overlap from various entrance an-
gles has been demonstrated. Experimentation on how PVDR
varies with beam separation given a divergent beam has also
been achieved, providing a starting point for future research
on MRT from divergent sources. Moreover, the precision of
the collimation and alignment system demonstrated here also
highlights the capability of beam interlacing within the target
region of interest.
We have also demonstrated the feasibility of creating a
compact device capable of delivering microbeam dose distri-
butions without the use of a synchrotron source by incorpo-
rating many of our CNT x-ray sources in tandem. These dose
distributions based upon our circular geometry will provide a
much lower entrance dose than that seen at synchrotron sites
while retaining their microplanar structure. Simultaneously,
such a design will allow for dose rates high enough to create
therapeutic microbeam doses in small animal studies using a
table-top source. It is our greatest hope that the resulting in-
crease in availability of MRT radiobiological studies will help
uncover more of the mechanisms behind the high therapeutic
ratios of MRT as demonstrated in small animals and possibly
open new avenues to be explored through which this promis-
ing new technique could be brought to future patients.
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